Why Different Heart Failure Blood Tests Give Different Answers — and Why That's a Problem
BNP and NT-proBNP heart failure blood tests produce markedly different results depending on which lab instrument is used, because there are no universal standards for measuring these peptide biomarkers.
Quick Facts
What This Study Found
Different commercial immunoassays for BNP and NT-proBNP produce markedly different results that are not comparable to each other. There is currently no certified reference material or standardized calibration approach for either biomarker, meaning that diagnostic cut-off values are method-dependent rather than universal.
The lack of equivalence stems partly from the complex nature of circulating BNP-related peptides — BNP exists in multiple forms in blood (precursors, fragments, glycosylated variants), and different assays detect different combinations of these forms.
Key Numbers
BNP discovered in 1988 · Multiple commercial assays with non-comparable results · No certified reference material exists · No standardized calibration procedures
How They Did This
This is a review chapter in Advances in Clinical Chemistry that synthesizes data on the molecular forms of circulating BNP-related peptides, compares the specificity and performance of existing commercial BNP and NT-proBNP immunoassays, and evaluates potential approaches for standardization including reference materials and measurement procedures.
Why This Research Matters
BNP and NT-proBNP blood tests are used millions of times yearly to diagnose heart failure, guide treatment decisions, and assess prognosis. If different lab instruments give different numbers for the same blood sample, doctors may misinterpret results — especially when patients switch hospitals or labs. Standardizing these peptide measurements is essential for consistent cardiac care worldwide.
The Bigger Picture
This standardization challenge affects every hospital using natriuretic peptide testing for heart failure — which is essentially all of them. The problem illustrates a broader issue in peptide diagnostics: when the target molecule exists in multiple forms (precursors, fragments, modified variants), a single number can mean different things depending on which forms the assay detects. Solving this for BNP/NT-proBNP could create a template for standardizing other peptide biomarker measurements.
What This Study Doesn't Tell Us
As a review, this paper does not present new experimental data. The standardization solutions discussed are proposals rather than implemented systems. The review was published in 2018 and the standardization landscape may have evolved since.
Questions This Raises
- ?Has a certified reference material for BNP or NT-proBNP been developed since this 2018 review?
- ?Could mass spectrometry-based methods replace immunoassays to provide more standardized BNP measurements?
- ?How many clinical misdiagnoses or treatment errors result from the current lack of assay equivalence?
Trust & Context
- Key Stat:
- No standard exists There is no certified reference material for calibrating BNP or NT-proBNP assays, making results method-dependent
- Evidence Grade:
- This is a comprehensive review published in a respected clinical chemistry series, synthesizing comparative assay data and peptide biochemistry. While authoritative, it proposes solutions rather than validating them, and the field may have progressed since 2018.
- Study Age:
- Published in 2018, this review addresses a standardization gap that remains partially unresolved. Some progress on harmonization has been made since, but full standardization of natriuretic peptide assays has not yet been achieved.
- Original Title:
- Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.
- Published In:
- Advances in clinical chemistry, 85, 1-30 (2018)
- Authors:
- Semenov, Alexander G(2), Feygina, Evgeniya E
- Database ID:
- RPEP-03892
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What are BNP and NT-proBNP and why are they tested?
BNP (brain natriuretic peptide) and NT-proBNP are peptides released by heart muscle cells when the heart is under strain. Measuring their blood levels is one of the main ways doctors diagnose heart failure, assess its severity, and track whether treatment is working.
Why do different labs give different BNP results for the same patient?
BNP circulates in blood in multiple molecular forms — the active peptide, its precursor, fragments, and modified variants. Different commercial tests detect different combinations of these forms, and without a universal calibration standard, each test produces its own scale of numbers.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03892APA
Semenov, Alexander G; Feygina, Evgeniya E. (2018). Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.. Advances in clinical chemistry, 85, 1-30. https://doi.org/10.1016/bs.acc.2018.02.001
MLA
Semenov, Alexander G, et al. "Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.." Advances in clinical chemistry, 2018. https://doi.org/10.1016/bs.acc.2018.02.001
RethinkPeptides
RethinkPeptides Research Database. "Standardization of BNP and NT-proBNP Immunoassays in Light o..." RPEP-03892. Retrieved from https://rethinkpeptides.com/research/semenov-2018-standardization-of-bnp-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.